Center for Environmental Health Sciences, University of Montana, Missoula, MT, USA.
Inhal Toxicol. 2024 Jan;36(1):31-43. doi: 10.1080/08958378.2024.2305112. Epub 2024 Jan 23.
Lysosomal ion channels are proposed therapeutic targets for a number of diseases, including those driven by NLRP3 inflammasome-mediated inflammation. Here, the specific role of the lysosomal big conductance Ca-activated K (BK) channel was evaluated in a silica model of inflammation in murine macrophages. A specific-inhibitor of BK channel function, paxilline (PAX), and activators NS11021 and NS1619 were utilized to evaluate the role of lysosomal BK channel activity in silica-induced lysosomal membrane permeabilization (LMP) and NLRP3 inflammasome activation resulting in IL-1β release.
Murine macrophages were exposed to crystalline silica following pretreatment with BK channel inhibitors or activators and LMP, cell death, and IL-1β release were assessed. In addition, the effect of PAX treatment on silica-induced cytosolic K decrease was measured. Finally, the effects of BK channel modifiers on lysosomal pH, proteolytic activity, and cholesterol transport were also evaluated.
PAX pretreatment significantly attenuated silica-induced cell death and IL-1β release. PAX caused an increase in lysosomal pH and decrease in lysosomal proteolytic activity. PAX also caused a significant accumulation of lysosomal cholesterol. BK channel activators NS11021 and NS1619 increased silica-induced cell death and IL-1β release. BK channel activation also caused a decrease in lysosomal pH and increase in lysosomal proteolytic function as well as a decrease in cholesterol accumulation.
Taken together, these results demonstrate that inhibiting lysosomal BK channel activity with PAX effectively reduced silica-induced cell death and IL-1β release. Blocking cytosolic K entry into the lysosome prevented LMP through the decrease of lysosomal acidification and proteolytic function and increase in lysosomal cholesterol.
溶酶体离子通道被认为是许多疾病的治疗靶点,包括由 NLRP3 炎性体介导的炎症。在这里,我们评估了溶酶体大电导钙激活钾(BK)通道在小鼠巨噬细胞矽肺模型中的炎症中的特定作用。我们利用 BK 通道功能的特异性抑制剂(paxilline,PAX)以及激活剂 NS11021 和 NS1619 来评估溶酶体 BK 通道活性在矽诱导的溶酶体膜通透性(LMP)和 NLRP3 炎性体激活导致 IL-1β释放中的作用。
用 BK 通道抑制剂或激活剂预处理后,用结晶二氧化硅处理小鼠巨噬细胞,评估 LMP、细胞死亡和 IL-1β释放。此外,还测量了 PAX 处理对二氧化硅诱导的细胞质 K 减少的影响。最后,还评估了 BK 通道修饰剂对溶酶体 pH、蛋白水解活性和胆固醇转运的影响。
PAX 预处理显著减弱了二氧化硅诱导的细胞死亡和 IL-1β 释放。PAX 导致溶酶体 pH 升高和溶酶体蛋白水解活性降低。PAX 还导致溶酶体胆固醇显著积累。BK 通道激活剂 NS11021 和 NS1619 增加了二氧化硅诱导的细胞死亡和 IL-1β 释放。BK 通道激活还导致溶酶体 pH 降低和溶酶体蛋白水解功能增强,以及胆固醇积累减少。
综上所述,这些结果表明,用 PAX 抑制溶酶体 BK 通道活性可有效减少二氧化硅诱导的细胞死亡和 IL-1β 释放。通过降低溶酶体酸化和蛋白水解功能以及增加溶酶体胆固醇来阻止细胞质 K 进入溶酶体,可防止 LMP。